Alembic Pharmaceuticals has informed the exchange that the Company's wholly owned subsidiary, Aleor Dermaceuticals Limited has received US Food and Drug Administration (USFDA) Final Approval for Adapalene and Benzoyl Peroxide Topical Gel, 0.3%/2.5%. The company has enclosed a press release in this regard.
The above information is a part of company’s filings submitted to BSE.